On the savings to small businesses, for example, Canadians would be able to afford their medication and, of course, would have cost savings. In reading through the report, I didn't see a specific estimate of the savings to small businesses. Is that because it's difficult to estimate? Or do you have some sense of it? Small businesses that care about their employees finance health care plans that include medication. Some of the figures I've seen from other sources indicate that small businesses would save billions of dollars if we had a national pharmacare plan, which actually means that this would be a very smart, competitive advantage to Canadians.
I have a final point I'd like to make. In terms of our medicare, I've seen estimates that for a Canadian company the average competitive advantage of our universal medicare system is about $3,000 an employee, as compared to their United States competitors. In other words, with medicare, a Canadian company saves $3,000 that a U.S. company would have to pay in employee health care plans to make sure they're balancing it off. Is that something you examined as well, that overall competitive advantage for Canadian businesses to have a national pharmacare program?